Anacor Pharmaceuticals Inc., of Palo Alto, Calif., said a peer-reviewed article describing the recent progress of boron-based compounds in medicine and the properties of these compounds that support their development for the treatment of various skin disorders will be published in the Journal of Clinical and Aesthetic Dermatology.